PJHRX Mutual Fund (PGIM Jennison Health Sciences Fund Class R) is managed by PGIM Investments with $5.2M in net assets. PJHRX expense ratio is 1.48%, holding 51 positions across sectors including Health Care, Unknown, Other. Inception date: 2012-02-03.

PJHRX performance shows a YTD return of 8.03%. The 1-year return is 36.03% and the 5-year return is 4.86%. PJHRX dividend yield stands at 14.35%, paid annually.

PJHRX top holdings include Eli Lilly & Co (16.8%), Hungarian Forint (7.7%), Merck & Company Inc (6.0%), Gilead Sciences Inc (4.4%), Unitedhealth Group Incorporated (4.3%). View all PJHRX holdings, sector breakdown, or dividend history.

PJHRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PJHRX alternatives are available via the screener, along with tax-loss harvesting opportunities.